文献速递腹部泌尿生殖CT

基于机器学习的CT鉴别肾细胞癌与良性肾肿瘤:比较不同成像期相、层面、肿瘤大小及ROI分割策略

Distinguishing common renal cell carcinomas from benign renal tumors based on machine learning: comparing various CT imaging phases, slices, tumor sizes, and ROI segmentation strategies.
PubMed 文献 · Eur Radiol · 2023-01-16

该研究纳入本机构2008-2020年病理证实的418例肾细胞癌和78例良性肾肿瘤作为训练集,并纳入两个独立机构及公共数据库TCIA的262例肾细胞癌和47例良性肾肿瘤作为外部测试集。基于三期CT图像提取特征,采用CatBoost建立机器学习模型,评估不同期相、层面、肿瘤大小及ROI分割策略对鉴别诊断性能的影响。结果显示基于3D图像的机器学习模型AUC最高为0.81,准确率0.86,三位放射科医生参考模型决策后准确率分别从0.82提升至0.87、0.82至0.88、0.76至0.87。

要点

  • 基于全肿瘤三期CT的机器学习分类器有助于鉴别肾细胞癌与良性肾肿瘤。
  • 机器学习模型与放射科医生判断互补,模型阴性预测值高(0.82-0.99),医生阳性预测值高(0.91-0.95)。
  • ROI勾画的细微差异对机器学习分类器性能影响较小。

诊断标准与关键数值

  • 基于3D图像的机器学习模型性能优于基于2D图像的模型,最高AUC为0.81,准确率(ACC)为0.86。
  • 三位放射科医生参考分类器决策后准确率分别从0.82提升至0.87、0.82提升至0.88、0.76提升至0.87。
  • 机器学习模型阴性预测值(NPV)范围为0.82-0.99,放射科医生阳性预测值(PPV)范围为0.91-0.95。
  • ROI勾画的细微差异对机器学习分类器性能影响较小。

临床应用与阅片要点

  • 在日常阅片中可参考机器学习分类器的阴性预测值高的特点,辅助排除良性肾肿瘤。
  • 放射科医生可结合模型决策提高鉴别肾细胞癌与良性肾肿瘤的准确率。
  • ROI勾画时无需过度追求精确,细微差异对模型性能影响小。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To determine whether a CT-based machine learning (ML) can differentiate benign renal tumors from renal cell carcinomas (RCCs) and improve radiologists' diagnostic performance, and evaluate the impact of variable CT imaging phases, slices, tumor sizes, and region of interest (ROI) segmentation strategies.

METHODS: Patients with pathologically proven RCCs and benign renal tumors from our institution between 2008 and 2020 were included as the training dataset for ML model development and internal validation (including 418 RCCs and 78 benign tumors), and patients from two independent institutions and a public database (TCIA) were included as the external dataset for individual testing (including 262 RCCs and 47 benign tumors). Features were extracted from three-phase CT images. CatBoost was used for feature selection and ML model establishment. The area under the receiver operating characteristic curve (AUC) was used to assess the performance of the ML model.

RESULTS: The ML model based on 3D images performed better than that based on 2D images, with the highest AUC of 0.81 and accuracy (ACC) of 0.86. All three radiologists achieved better performance by referring to the classifier's decision, with accuracies increasing from 0.82 to 0.87, 0.82 to 0.88, and 0.76 to 0.87. The ML model achieved higher negative predictive values (NPV, 0.82-0.99), and the radiologists achieved higher positive predictive values (PPV, 0.91-0.95).

CONCLUSIONS: A ML classifier based on whole-tumor three-phase CT images can be a useful and promising tool for differentiating RCCs from benign renal tumors. The ML model also perfectly complements radiologist interpretations.

KEY POINTS: • A machine learning classifier based on CT images could be a reliable way to differentiate RCCs from benign renal tumors. • The machine learning model perfectly complemented the radiologists' interpretations. • Subtle variances in ROI delineation had little effect on the performance of the ML classifier.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Zhou, Guan, Feng, et al. Distinguishing common renal cell carcinomas from benign renal tumors based on machine learning: comparing various CT imaging phases, slices, tumor sizes, and ROI segmentation strategies. Eur Radiol. 2023. PMID: 36645455. doi:10.1007/s00330-022-09384-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。